VANTIVE LIMITED
Get an alert when VANTIVE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-18 (in 2mo)
Last made up 2025-07-04
Watchouts
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
2 PSCs ceased in last 24 months
Significant control changed hands — see the Ownership section.
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After reviewing the Company's forecasts and projections, taking account of a severe but plausible change in trading performance, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company is secured to continue its operating activities with financial support from the parent company if required and through its cash pooling arrangement with the Group. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Group structure
- VANTIVE LIMITED · parent
- Vantive Limited Liability Company 99.8%
Significant events
- “On 31 January 2025, Baxter Healthcare Holding Limited, a company incorporated in Malta, sold its 100% interests in Vantive Health GmbH, 48% interest of Vantive Holding Limited and 100% interests in Vantive Holding B.V., a company incorporated in Netherlands, who indirectly owns the Company thru Vantive UK LLC, to Spruce Bid Co I Limited, a company incorporated in Ireland, in exchange for $1,423,187K cash.”
- “On 1 February 2025, Vantive, formerly the Baxter Kidney Care segment, was launched as a new standalone vital organ therapy company following the completion of its acquisition by CP Spuce Holdings, S.C.Sp., funds managed by global investment firm Carlyle, from BII.”
- “After the Global separation, the Company's ultimate parent company has changed to Vantive Limited (formerly Spruce TopCo Limited), a company registered in Jersey.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOA, Cassandra | Director | 2024-10-10 | Aug 1989 | Irish |
| WARBURTON, Andrew John | Director | 2023-08-31 | Sep 1974 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FITZGERALD, Nicola Maria | Director | 2024-04-26 | 2024-09-27 |
| O'NEILL, Gerard Patrick | Director | 2023-07-05 | 2023-08-31 |
| SMIALEK, Michal Maciej | Director | 2023-07-05 | 2024-04-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| The Carlyle Group, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-01-31 | Active |
| Baxter International Incorporated | Corporate entity | Shares 75–100% | 2024-12-08 | Ceased 2025-01-31 |
| Baxter Healthcare Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-07-05 | Ceased 2024-12-08 |
Filing timeline
Last 20 of 22 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-07-30 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-23 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-07-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-26 | AA | accounts | Accounts with accounts type full | |
| 2025-06-23 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-20 | MA | incorporation | Memorandum articles | |
| 2025-06-13 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-14 | SH01 | capital | Capital allotment shares | |
| 2025-01-08 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-01-08 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-10-14 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-29 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-09-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-09-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-01 | CERTNM | change-of-name | Certificate change of name company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one